Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

https://www.tipranks.com/news/the-fly/resmed-initiated-with-an-overweight-at-morgan-stanley-2 Morgan Stanley analyst David Bailey initiated coverage of ResMed (RMD ...

ResMed (NYSE:RMD) has had a rough month with its share price down 7.5%. However, stock prices are usually driven by a company’s financial performance over the long term, which in this case looks quite ...

ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the ...

ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability. The great quarter was driven by high ...

ResMed specializes in designing and manufacturing devices and software solutions for sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Its commitment to ...